• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与破骨细胞分化的表观遗传调节剂。

Epigenetic Regulators Involved in Osteoclast Differentiation.

机构信息

Department of Developmental and Surgical Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Int J Mol Sci. 2020 Sep 25;21(19):7080. doi: 10.3390/ijms21197080.

DOI:10.3390/ijms21197080
PMID:32992908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583862/
Abstract

Age related changes to the skeleton, such as osteoporosis, increase the risk of fracture and morbidity in the elderly population. In osteoporosis, bone remodeling becomes unbalanced with an increase in bone resorption and a decrease in bone formation. Osteoclasts are large multinucleated cells that secrete acid and proteases to degrade and resorb bone. Understanding the molecular mechanisms that regulate osteoclast differentiation and activity will provide insight as to how hyper-active osteoclasts lead to pathological bone loss, contributing to diseases such as osteoporosis. Reversible modifications to the DNA such as histone acetylation, methylation, phosphorylation and ubiquitylation alters the access of transcriptional machinery to DNA and regulates gene expression and osteoclast differentiation and activity. It is critical for the management of bone related diseases to understand the role of these chromatin modifying proteins during osteoclast differentiation, as potential therapies targeting these proteins are currently under development.

摘要

骨骼的年龄相关性变化,如骨质疏松症,会增加老年人群骨折和发病的风险。在骨质疏松症中,骨重建变得不平衡,骨吸收增加,骨形成减少。破骨细胞是大型多核细胞,可分泌酸和蛋白酶降解和吸收骨。了解调节破骨细胞分化和活性的分子机制将深入了解过度活跃的破骨细胞如何导致病理性骨质流失,从而导致骨质疏松症等疾病。DNA 的可逆修饰,如组蛋白乙酰化、甲基化、磷酸化和泛素化,改变转录机制与 DNA 的接触,调节基因表达和破骨细胞分化和活性。了解这些染色质修饰蛋白在破骨细胞分化过程中的作用对于骨骼相关疾病的治疗至关重要,因为目前正在开发针对这些蛋白的潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/3178a60d80f8/ijms-21-07080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/5f279e950f0b/ijms-21-07080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/95bddd269d5e/ijms-21-07080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/3178a60d80f8/ijms-21-07080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/5f279e950f0b/ijms-21-07080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/95bddd269d5e/ijms-21-07080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7583862/3178a60d80f8/ijms-21-07080-g003.jpg

相似文献

1
Epigenetic Regulators Involved in Osteoclast Differentiation.参与破骨细胞分化的表观遗传调节剂。
Int J Mol Sci. 2020 Sep 25;21(19):7080. doi: 10.3390/ijms21197080.
2
Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation.骨重塑:组蛋白修饰作为骨细胞分化命运的决定因素。
Int J Mol Sci. 2019 Jun 27;20(13):3147. doi: 10.3390/ijms20133147.
3
Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development.骨组织完整性和骨质疏松症发病的表观遗传调控
Int J Mol Sci. 2020 Jul 12;21(14):4923. doi: 10.3390/ijms21144923.
4
Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis.骨重塑的表观遗传调控及其对骨质疏松症的影响
Int J Mol Sci. 2016 Sep 1;17(9):1446. doi: 10.3390/ijms17091446.
5
New insights into the epigenetics of osteoporosis.骨质疏松症表观遗传学的新见解。
Genomics. 2019 Jul;111(4):793-798. doi: 10.1016/j.ygeno.2018.05.001. Epub 2018 May 4.
6
Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases.组蛋白去乙酰化酶对破骨细胞分化和骨骼维持的调控。
Molecules. 2019 Apr 6;24(7):1355. doi: 10.3390/molecules24071355.
7
Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.生物分子在破骨细胞中的作用及其在骨质疏松症治疗中的潜力。
Biomolecules. 2021 May 17;11(5):747. doi: 10.3390/biom11050747.
8
ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.ASXL1 通过表观遗传调控 NFATc1 来抑制破骨细胞的形成。
Blood Adv. 2018 Oct 9;2(19):2467-2477. doi: 10.1182/bloodadvances.2018018309.
9
Epigenetic regulation of osteoclast differentiation.破骨细胞分化的表观遗传调控。
Ann N Y Acad Sci. 2011 Dec;1240:7-13. doi: 10.1111/j.1749-6632.2011.06245.x.
10
Autophagy-dependent mitochondrial function regulates osteoclast differentiation and maturation.自噬依赖性线粒体功能调节破骨细胞分化和成熟。
Biochem Biophys Res Commun. 2020 Jul 5;527(4):874-880. doi: 10.1016/j.bbrc.2020.04.155. Epub 2020 May 16.

引用本文的文献

1
Beyond Bone Loss: A Biology Perspective on Osteoporosis Pathogenesis, Multi-Omics Approaches, and Interconnected Mechanisms.超越骨质流失:骨质疏松症发病机制、多组学方法及相互关联机制的生物学视角
Biomedicines. 2025 Jun 12;13(6):1443. doi: 10.3390/biomedicines13061443.
2
Lysine specific demethylase 1 conditional myeloid cell knockout mice have decreased osteoclast differentiation due to increased IFN- gene expression.赖氨酸特异性去甲基化酶1条件性髓样细胞敲除小鼠由于干扰素基因表达增加,破骨细胞分化减少。
JBMR Plus. 2024 Nov 9;9(1):ziae142. doi: 10.1093/jbmrpl/ziae142. eCollection 2025 Jan.
3
Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging.

本文引用的文献

1
Monocyte Subsets With High Osteoclastogenic Potential and Their Epigenetic Regulation Orchestrated by IRF8.具有高破骨细胞生成潜能的单核细胞亚群及其由IRF8精心调控的表观遗传学机制
J Bone Miner Res. 2021 Jan;36(1):199-214. doi: 10.1002/jbmr.4165. Epub 2020 Sep 11.
2
Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.衰老和更年期会对破骨细胞前体进行重编程,以促进活跃的骨吸收。
Bone Res. 2020 Jul 1;8:27. doi: 10.1038/s41413-020-0102-7. eCollection 2020.
3
regulates the action of nitrogen-containing bisphosphonates on bone.
破骨细胞与骨关节炎:衰老过程中新型干预靶点与治疗潜能。
Aging Cell. 2024 Apr;23(4):e14092. doi: 10.1111/acel.14092. Epub 2024 Jan 29.
4
Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review.参与骨再生过程的植物化学化合物及其创新给药方式:一项系统综述。
Plants (Basel). 2023 May 22;12(10):2055. doi: 10.3390/plants12102055.
5
The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts.组蛋白去甲基化酶 KDM5C 通过促进破骨细胞的能量代谢来控制女性的骨量。
Sci Adv. 2023 Apr 5;9(14):eadg0731. doi: 10.1126/sciadv.adg0731.
6
The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts.组蛋白去甲基化酶KDM5C通过促进破骨细胞的能量代谢来控制女性骨量。
bioRxiv. 2023 Feb 23:2023.02.23.529728. doi: 10.1101/2023.02.23.529728.
7
Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation.赖氨酸特异性组蛋白去甲基化酶 1 在 RANKL 介导的破骨细胞分化中的关键作用。
Int J Mol Sci. 2023 Feb 10;24(4):3605. doi: 10.3390/ijms24043605.
8
RANK signaling in osteoclast precursors results in a more permissive epigenetic landscape and sexually divergent patterns of gene expression.RANK 信号在破骨细胞前体中导致了更具许可性的表观遗传景观和性别差异的基因表达模式。
PeerJ. 2023 Feb 9;11:e14814. doi: 10.7717/peerj.14814. eCollection 2023.
9
Role of chromatin modulator Dpy30 in osteoclast differentiation and function.染色质修饰因子 Dpy30 在破骨细胞分化和功能中的作用。
Bone. 2022 Jun;159:116379. doi: 10.1016/j.bone.2022.116379. Epub 2022 Mar 16.
10
Bone Phenotyping Approaches in Human, Mice and Zebrafish - Expert Overview of the EU Cost Action GEMSTONE ("GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork").人类、小鼠和斑马鱼中的骨骼表型分析方法——EU COST 行动 GEMSTONE(“肌肉骨骼特征转化遗传学网络”)专家综述。
Front Endocrinol (Lausanne). 2021 Dec 1;12:720728. doi: 10.3389/fendo.2021.720728. eCollection 2021.
调节含氮双膦酸盐对骨骼的作用。
Sci Transl Med. 2020 May 20;12(544). doi: 10.1126/scitranslmed.aav9166.
4
METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.METTL3 通过控制 RNA 稳定性和核输出调节破骨细胞分化和功能。
Int J Mol Sci. 2020 Feb 28;21(5):1660. doi: 10.3390/ijms21051660.
5
EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets.EZH2通过表观遗传和细胞质靶点支持破骨细胞分化和骨吸收。
J Bone Miner Res. 2020 Jan;35(1):181-195. doi: 10.1002/jbmr.3863. Epub 2019 Oct 23.
6
Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases.组蛋白去乙酰化酶对破骨细胞分化和骨骼维持的调控。
Molecules. 2019 Apr 6;24(7):1355. doi: 10.3390/molecules24071355.
7
Deregulated miRNAs in bone health: Epigenetic roles in osteoporosis.骨健康中失调的 miRNAs:骨质疏松症中的表观遗传作用。
Bone. 2019 May;122:52-75. doi: 10.1016/j.bone.2019.02.013. Epub 2019 Feb 14.
8
Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.PU.1 与 IRF8 和 NFATc1 的合作定义了 RANKL 诱导的破骨细胞分化过程中的染色质景观。
J Bone Miner Res. 2019 Jun;34(6):1143-1154. doi: 10.1002/jbmr.3689. Epub 2019 Feb 28.
9
Eomes partners with PU.1 and MITF to Regulate Transcription Factors Critical for osteoclast differentiation.Eomes与PU.1和MITF合作,调控破骨细胞分化关键转录因子。
iScience. 2019 Jan 25;11:238-245. doi: 10.1016/j.isci.2018.12.018. Epub 2018 Dec 27.
10
ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.ASXL1 通过表观遗传调控 NFATc1 来抑制破骨细胞的形成。
Blood Adv. 2018 Oct 9;2(19):2467-2477. doi: 10.1182/bloodadvances.2018018309.